Mechanisms of beta-cell death in type 2 diabetes

Marc Y Donath1, Jan A Ehses, Kathrin Maedler

  • 1Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. marc.donath@usz.ch

Diabetes
|November 25, 2005
PubMed

Insights

Type 2 diabetes involves reduced functional beta-cells. This review explores how factors like glucose and inflammation impact beta-cell function and survival through various molecular mechanisms.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pathophysiology

Background:

  • Type 2 diabetes is characterized by a decline in functional insulin-producing beta-cells.
  • The exact contribution of reduced beta-cell mass versus impaired secretory function remains debated.
  • Multiple factors are implicated in beta-cell dysfunction.

Purpose of the Study:

  • To review the evidence linking various factors to beta-cell maladaptation in type 2 diabetes.
  • To elucidate the molecular mechanisms underlying beta-cell dysfunction.
  • To highlight the interconnectedness of beta-cell regulation, inflammation, and turnover.

Main Methods:

  • Literature review of studies on type 2 diabetes pathophysiology.
  • Focus on specific causal factors: glucose, dyslipidemia, cytokines, leptin, autoimmunity, sulfonylureas.
  • Examination of molecular mechanisms: Fas, ATP-sensitive K+ channel, IRS-2, oxidative stress, NF-κB, ER stress, mitochondrial dysfunction.

Main Results:

  • Glucose, dyslipidemia, cytokines, leptin, autoimmunity, and sulfonylureas contribute to beta-cell maladaptation.
  • These factors act through specific molecular pathways including Fas, K+ channels, IRS-2, oxidative stress, NF-κB, ER stress, and mitochondrial dysfunction.
  • Many implicated factors are involved in inflammatory processes.

Conclusions:

  • Beta-cell function, proliferation, and apoptosis are tightly regulated and influenced by common pathways.
  • Inflammation plays a significant role in beta-cell dysfunction and loss.
  • Understanding these interconnected mechanisms is crucial for type 2 diabetes research.

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.